Can a smartphone app help cancer patients stick to their pill schedule?
NCT ID NCT06952790
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a mobile app called EveryDose to see if it helps cancer patients take their oral chemotherapy medications on time. About 25 adults with cancer who are starting a new oral chemo drug will use the app for 12 weeks. The goal is to learn if the app is easy to use and if it improves how well patients follow their medication plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?